Grants for State governments - Food and Nutrition

The purpose of this funding opportunity announcement (FOA) is to support efficient natural history studies alone or in conjunction with the development and validation of clinical outcome assessments (COAs) and/or biomarker studies to address the unmet needs in rare neurodegenerative diseases for children and adults. Through the support of studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare neurodegenerative disease or multiple rare neurodegenerative diseases with similar pathophysiology, and facilitate rare disease product development.

This grant provides funding to teams of creatives and community members in Massachusetts to explore and develop public art projects that promote spatial and racial justice in their communities.

This funding opportunity provides financial support for new and underrepresented researchers in the health sciences to conduct projects aligned with the missions of NIAID or NIDDK.

This grant provides $25,000 to nonprofit organizations and community groups in the U.S. to investigate and address environmental factors linked to cancer in underserved communities.

The U.S. Food and Drug Administration (FDA) seeks applications to develop, implement, and evaluate a human abuse potential (HAP) study of botanical Kratom. FDA has previously warned consumers about the use of Kratom (Mitragyna speciosa), a plant indigenous to Southeast Asia. Kratom alkaloids have demonstrated both affinity and activity at receptor sites known to be associated with abuse, such as mu opioid receptors. Although Kratom use is prevalent, to date, clinical evaluations of its abuse potential have been limited. The proposed HAP study should be performed in accordance with the guidance for industry, "Assessment of Abuse Potential of Drugs," including (but not limited to) the selection of an appropriate comparator(s) and outcome measures, statistical analyses etc. Interested parties, will also complete the submission of an Investigational New Drug (IND) application and obtain Institutional Review Board (IRB) clearance.

This grant provides funding for innovative research on the effects of HIV on aging, targeting projects that explore the health and quality of life of older adults living with HIV.

This grant provides funding for research aimed at understanding the factors that contribute to health disparities in HIV and aging among racial and ethnic minorities, low-income populations, and other underserved groups, focusing on how multiple health conditions affect their overall well-being and quality of life.

This funding opportunity supports high-risk, multi-center clinical trials aimed at addressing significant health issues related to diabetes, digestive diseases, and kidney disorders, encouraging diverse institutions to apply for impactful research that can transform clinical practices.

The MIT Environmental Solutions Journalism Fellowship offers $10,000 plus up to $5,000 for expenses to U.S. journalists, both freelance and staff, to develop a news project that localizes the impact of climate change and the transition to a low-carbon economy, with a focus on local perspectives and solutions, aiming to engage and empower their audience.

This initiative provides $4.1 million to Tribal Colleges and Universities to develop innovative, student-led projects that combine clean energy solutions with sustainable food practices, empowering students and enhancing food sovereignty on Tribal lands.

This program provides funding for Wisconsin-based small businesses, nonprofits, and local governments to purchase equipment that enhances the processing, storage, and distribution of locally produced food products.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

This program provides funding to state, territory, and Tribal governments to purchase local foods from underserved producers and improve food access in communities with limited resources.

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) that were developed for the treatment of type 2 diabetes (T2D) have significant protective effects for cardiac and renal diseases for people with and without diabetes. However, SGLT2i are not currently approved for individuals with type 1 diabetes (T1D) and there is an increased risk of diabetic ketoacidosis (DKA) for this population. Despite this concern, these drugs are increasingly being prescribed off-label for people with T1D. Continuous ketone monitoring (CKM) is a rapidly evolving technology that could be utilized clinically to prevent DKA by an early warning of elevations in ketone levels.The purpose of this NOFO is to solicit applications for studies that will develop and test risk mitigation strategies that involve the clinical integration of CKM for the safe use of SGLT2i for people living with T1D so that they may benefit from the cardiac and renal protection and glucose-lowering effects of this drug class. The NOFO will support short-term, clinical trials to gain and disseminate knowledge on safety and glucose control with CKM and SGLT2i use.Possible topics include testing optimal insulin delivery in open and closed loop systems or multiple daily injections and developing clinical protocols to control or ameliorate elevated ketone levels in individuals with T1D who are receiving adjunct therapy with SGLT2i.

FDA announces the availability of fiscal year (FY) 2024 funds to support one or more projects to 1) collect antimicrobial use data from diverse animal sectors, including domestic livestock, poultry, companion animals (dogs, cats, and horses), and minor species (e.g., fish, sheep, goats, etc.) and 2) contribute to the development of data collection frameworks, including providing data and expertise as resources and a public-private partnership frameworks are established.This grant will support the continued advancement of FDA's initiatives to support antimicrobial stewardship in veterinary settings. It will also support the National Action Plan objectives to engage the animal health community and relevant stakeholders to advance strategies intended to improve understanding of antimicrobial use and foster antimicrobial stewardship in animal agriculture.

This funding supports institutions in developing training programs for predoctoral and postdoctoral researchers in biomedical and clinical fields, with a focus on enhancing diversity and preparing trainees for successful research careers.

This funding opportunity supports interdisciplinary research teams to explore how medical devices can effectively relieve chronic pain while minimizing addiction risks.

This track of the Resilient Food Systems Infrastructure (RFSI) program provides approximately $1 million for grants aimed at purchasing equipment necessary for the middle of the food supply chain activities in Vermont. The grants range from $30,000 to $100,000 with no match requirement. Applications for this track are set to open in late August 2024 and close in early October 2024, with grant activities beginning in early 2025.

Through the support of the Centers for Disease Control and Prevention (CDC), the Urban Indian Health Institute (UIHI) launched a nationwide initiative to not only enhance evidence-based culturally rigorous chronic disease prevention programs but also to enhance public health infrastructure among urban Indian organizations. This initiative aligns with UIHI's mission to serve urban Indian communities by promoting health and preventing chronic diseases through culturally appropriate approaches. The grant program, called Sweetgrass funds, focuses on Indigenous approaches to preventing chronic diseases. The target beneficiaries of this grant are Urban Indian Organizations (UIOs) as defined by the Indian Health Service (Title V programs), members of the National Urban Indian Family Coalition (NUIFC), and not-for-profit urban Indian organizations whose leadership and board are majority urban Indian, and whose mission is to provide public health services to urban Indians. The impact goals are to address and prevent chronic diseases such as obesity, commercial tobacco use, Type 2 Diabetes, and heart disease and stroke within these communities. The program encourages the use of AI/AN traditional, cultural, and regional knowledge in developing and implementing chronic disease education, prevention, and management initiatives. The program prioritizes expanding previous projects related to obesity prevention, commercial tobacco use prevention and cessation promotion, Type 2 Diabetes prevention, and heart disease and stroke prevention. Specific approaches include using cultural or regional adaptations of chronic disease prevention education program components, reclaiming traditional knowledge of nutrition and first foods, promoting access to physical activity and lifestyle modifications, engaging Native youth and elders, addressing perceptions and beliefs, promoting traditional values, and emphasizing community-driven planning for chronic disease prevention and control, such as community needs assessments. Expected outcomes include enhanced evidence-based and culturally rigorous chronic disease prevention programs, improved public health infrastructure among urban Indian organizations, and a reduction in the prevalence of chronic diseases within urban Indian communities. Applicants are required to participate in performance measurement, evaluation activities, and a chronic disease community of practice, which includes annual webinar-based trainings and optional technical assistance services, all coordinated by UIHI. This structured approach ensures measurable results and continuous improvement in addressing chronic diseases with a broad reach across the United States.

This funding opportunity supports promising predoctoral students in health-related fields to receive personalized research training and mentorship, helping them develop into independent research scientists.